Optimer licensing agreements and repeat custom
Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics
View articleLicensing with a global enzyme provider for two Optimer reagents in research and diagnostics
View articleGrowth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
View articleNew solutions from Siemens Healthineers address labs’ environmental and efficiency goals
View articleVote for the product that has made the most difference to your lab for the chance to win a $100 Amazon Gift Card (or equivalent currency)
View articleFrom synthetic biology to microbiome and food safety research, the QPix FLEX system gives researchers the power to accelerate discovery, reduce hands-on time, and streamline their entire microbial screening process
View articleBUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at every stage of the supply chain
View articleDesigned to enable scientists to conduct small-scale experiments quickly and affordably
View articleNew data show Optimer delivery vehicle could be used in precision medicines across diverse fibrotic diseases
View articleThe acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
View articleData to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress
View articleAs scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease
View articleA study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival
View articleLaboratory water quality is often overlooked but plays a pivotal role in ensuring accuracy, compliance, and reproducibility
View articleHear how researchers have discovered a new cellular mechanism that controls the stability of messenger RNA (mRNA) in cells
View articleNew solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow
View article1 in 3 Phase II trials were terminated in 2024
View articleThe UG 100 offers a cost-effective and extremely low-error sequencing profile
View articleDive into a new era of intelligence and performance with Agilent's upcoming virtual launch
View articleBy developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
View articleEnhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques
View articleDrug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
View articleThe Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
View article